A study to Indicate the Infection Prevalence with the Giardia lamblia and Entameoba histolytica parasites in Al Najaf Governorate for the year 2022
DOI:
https://doi.org/10.46966/msjar.v5i3.215Keywords:
Parasite, E.histolytica, G.lambliaAbstract
Background: study of parasitic infection is considered one of the challenges in maintainable progress. Aim: It is a statement of the prevalence of parasite infection in Najaf Governorate for the year 2022 for some age groups. Methods: Data for the study are collected from the Digestive System Hospital in Al-Najaf Governorate, and they are analyzed, showing the percentages of infections with both parasites, and showing the environment that encourages infection and its causes. Results: There were 622 specimens were collected from gastrointestinal patients who suffer from similar symptoms to some extent, which the parasitic infections were E.histolytica, and G.lamblia, found to be 620 (93.65%) with E.histolytica infection and 42 (6.34%) with G.lamblia infection, and the results showed that the highest rate of total infection in the age group from 15-45 years. And the least in age group 10-14 years. According to sex the highest infection were in females as total infections, and the results showed that the highest rate of G. lamblia infection in the age group from 15-45 years. And the least percentage in age more 45 years. And the highest percentage of E. histolytica infection in the age group from 15-45 years. And the least in age group 10-14 years. Conclusion: We conclude from this study that parasite infection especially G. lamblia and E. histolytica include all ages, sexes. but the most vulnerable age groups are in terms of bodily building and defensive immunity of the body.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Noor I. Abdul-Zahra, Zahraa K. Taiban

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















